MedPath

Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents

Phase 4
Conditions
Pancreatic Pseudocyst
Interventions
Procedure: EUS-guided pancreatic pseudocyst drainage
Registration Number
NCT01585662
Lead Sponsor
Xiaoyin Zhang
Brief Summary

EUS-guided pseudocyst drainage has been used world widely. Now, most endoscopists tend to place several stents to drain the content of cyst into GI tract. In the investigators experience, a modified naso-pancreatic tube drainage was more safer, easier and cheaper than placement of stents. Moreover, none of pseudocysts(total 19) drained by this modified naso-pancreatic tube drainage method were found recurrent with a follow up period from 3 months-34 months. So, the investigators designed this prospective random comparing study to confirm the result.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Adults with ages from 18-80 years old.
  2. The pseudocysts were formed more than 3 months.
  3. The size of pseudocyst is more than 5 cm.
  4. The patient has the symptoms related with the pseudocyst.
  5. The distance between gastric and the wall of the pseudocyst is less than 1 cm from CT image.
  6. The consent form has been signed.
Exclusion Criteria
  1. The patient can't accept the endoscopic procedure.
  2. The patient has blood coagulation dysfunction.
  3. The patient has mental disorders.
  4. The patient has mild or severe cardiorespiratory insufficiency.
  5. The patient has hypertension and can't be controlled to safe level.
  6. Diabetics whose blood sugar level can't be controlled to safe level.
  7. Patients with alcohol dependence
  8. Pregnant and lactating women.
  9. The patients the investigator don't think suitable for this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Naso-pancreatic tubeEUS-guided pancreatic pseudocyst drainageThe patients enrolled in this group will be treated with modified naso-pancreatic tube drainage method.
StentsEUS-guided pancreatic pseudocyst drainageThe patients enrolled this group will be treated by placing the stents (at least 2 stents) between gastric and pancreatic pseudocyst.
Primary Outcome Measures
NameTimeMethod
recurrence rate of pancreatic pseudocyst12 months
Secondary Outcome Measures
NameTimeMethod
The complication rate12 months

Trial Locations

Locations (1)

Xijing Institute of digestive diseases

🇨🇳

Xian city, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath